Getting a handle on Huntington's disease: the case for cholesterol

Katsuno, Masahisa; Adachi, Hiroaki; Sobue, Gen
March 2009
Nature Medicine;Mar2009, Vol. 15 Issue 3, p253
Academic Journal
The article focuses on the treatment for Huntington's disease. Huntington's disease is a hereditary neurodegenerative disease described by progressive movement disorder, cognitive decline, and psychiatric disturbances. It states that since 1872 various efforts have been made to cure it. Accordingly, a new study found out that targeting cholesterol metabolism can be a potential treatment, given that low concentrations of brain cholesterol may contribute to the disease.


Related Articles

  • Huntington Disease: Banking on ATM. Flemming, Alexandra // Nature Reviews Drug Discovery;Feb2015, Vol. 14 Issue 2, p92 

    The article presents a study by Yang and colleagues published in the journal "Science Translational Medicine," which examines that ataxia telangiectasia mutated protein (ATM), may used as treatment for patients with Huntington disease (HD). The research reveals that DNA damage in ATM upregualted...

  • Late-onset Huntington disease with intermediate CAG repeats: true or false? Groen, Justus L.; de Bie, Rob M. A.; Foncke, Elisabeth M. J.; Roos, Raymund A. C.; Leenders, Klaus L.; Tijssen, Marina A. J. // Journal of Neurology, Neurosurgery & Psychiatry;Feb2010, Vol. 81 Issue 2, p228 

    Huntington disease (HD) is a neurodegenerative disorder associated with an expanded CAG trinucleotide repeat length in the huntingtin gene. 'Intermediate alleles with 27 to 35 CAG repeats generally do not cause HD but are unstable upon germ-line transmission. Insights in CAG repeat mosaicism and...

  • HUNTINGTON'S-LIKE CURE ON THE WAY.  // Australasian Science;Jul2001, Vol. 22 Issue 6, p33 

    Reports on the gene discovered by Griffith University biomedical researcher Derek Kennedy for treating Huntington's-like disease. Signs and symptoms of the neurodegenerative disease; Problems in the diagnosis of the disease; Technique for discovering the disease.

  • Poster 16: Genetic Approach to Huntington's Disease Therapeutics MacDonald, M.; Lee, J. Min; Seong, I. Sik; Fossale, E.; Anderson, M.A.; Wheeler, V.; Gusella, J. // Neurotherapeutics;Jan2010, Vol. 7 Issue 1, p143 

    Background: Unlike other neurodegenerative disorders, Huntington''s disease, with its motor, behavioral, and cognitive deficits and early loss of neurons in the striatum, has a single cause: expanded versions of a polymorphic CAG repeat in the HTT gene (previously HD) of ≥35 units. This...

  • The Endocannabinoid System and Huntington's Disease. Lastres-Becker, I.; de Miguel, R.; Fern�ndez-Ruiz, J.J. // Current Drug Targets - CNS & Neurological Disorders;Oct2003, Vol. 2 Issue 5, p335 

    The research in Huntington's disease (HD) has been growing exponentially during the last decade, since the discovery of the genetic basis that leads to neurodegeneration. HD is one of several progressive neurodegenerative disorders, in which the underlying mutation is a CAG expansion encoding a...

  • Neurodegenerative disease: Attacking Huntington's from the inside out. Whalley, Katherine // Nature Reviews Neuroscience;Jul2008, Vol. 9 Issue 7, p500 

    The article discusses the study on the effects of interfering with mutant Huntingtin (HTT) accumulation by using the intrabody that selectively binds to human mutant HTT. Results suggest that cytoplasmic HTT accumulation has a role in the pathogenesis of Huntington's disease (HD) and could be a...

  • Huntington's centre faces closure. Wallerstein, Claire // BMJ: British Medical Journal (International Edition);08/12/2000, Vol. 321 Issue 7258, p404 

    Reports on the financial crisis faced by the Casa Hogar Huntington's disease care center in Maracaibo, Venezuela. Common symptoms of Huntington's disease; Incidence of the rare disease among the population surrounding the area; Details of research into the genetic causes of the disease; Impact...

  • Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington’s disease. Busse, Monica E.; Hughes, Gareth; Wiles, Charles M.; Rosser, Anne E. // Journal of Neurology;Oct2008, Vol. 255 Issue 10, p1534 

    Sub-clinical muscle involvement, including myopathic changes and mitochondrial dysfunction of skeletal muscle, has been reported in people with Huntington’s disease (HD). Muscle strength was evaluated using a hand-held dynamometer. Reliability and validity in people with HD were...

  • Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice. Boudreau, Ryan L.; McBride, Jodi L.; Martins, Inês; Shihao Shen; Yi Xing; Carter, Barrie J.; Davidson, Beverly L. // Molecular Therapy;Jun2009, Vol. 17 Issue 6, p1053 

    Huntington's disease (HD) is a fatal neurodegenerative disease caused by mutant huntingtin (htt) protein, and there are currently no effective treatments. Recently, we and others demonstrated that silencing mutant htt via RNA interference (RNAi) provides therapeutic benefit in HD mice. We have...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics